Delivery Order SPE2DB22D3301-SPE2DB25FX5DF

Award Date 11/7/24
Potential Completion Date 11/8/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of EPOGEN 10,000 units/mL vials, with a potential value of $1,178.00 and a completion date of February 20, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and...
This federal contract award, with ID SPE2DB20D3103|SPE2DB23FP0R5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,711.97 delivery order is for EPOGEN 2,000 units/mL vials and has a firm fixed price. The contract has a completion date of July 21, 2023 and was awarded on July 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and is a critical supplier of pharmaceutical products and medical supplies...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, a Delivery Order valued at $10,662.69, is for the delivery of EPKINLY 48 MG/0.8 ML VIAL 0.8ML. The contract is a Firm Fixed Price arrangement without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp also holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,609.34 firm fixed-price delivery order is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT. The contract has an ultimate completion date of April 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 40,000 units of PROCRIT (Epoetin alfa) 40,000 units/mL vials, with a ceiling value of $7,135.83 and an ultimate completion date of January 2, 2025. The contract is a firm fixed-price delivery order, and there was no set-aside designation indicated. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of epinephrine injection valued at $1,522.32. The contract has a firm fixed price and an ultimate completion date of July 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a wide range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,764.16 delivery order contract is for the procurement of 40,000 units of PROCRIT (Epoetin alfa), a medication used to treat anemia. The contract has an ultimate completion date of July 7, 2022 and is a firm fixed-price delivery order. There was no set-aside designation for this award. AmerisourceBergen holds a...
Defense Logistics Agency awarded a $1,129.31 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4,000 units/ml vials of Epoetin Alfa, also known as Epogen. The delivery order was awarded on October 17, 2023 under the prime contractor's corporate office division in Conshohocken, Pennsylvania, with performance required by October 18, 2023. No set-aside designation was applied to this procurement. Epogen is a medication commonly used to treat anemia, a condition addressed...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,987.40 firm-fixed-price contract is for the delivery of epinephrine 1 mg/10 mL syringes, with a final completion date of November 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,122.00, is a Delivery Order for the supply of EPINEPHRINE 1 MG/ML AMPU with a performance period through June 5, 2025. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX5DF
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,579.86, is for the delivery of Epogen 20,000 units/mL vials. This is a firm fixed-price contract with a completion date of November 8, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/6/25, 9:19 AM